IC
AUPH icon

IEQ Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

IEQ Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$327K Buy
22,088
+8,206
+59% +$120K ﹤0.01% 1482
2025
Q4 		$221K Buy
+13,882
New +$197K ﹤0.01% 1666
2025
Q2 		– Sell
-33,123
Closed -$266K – 1824
2025
Q1 		$266K Buy
+33,123
New +$268K ﹤0.01% 1237

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IEQ Capital's AUPH Position: Q1 2026 in Review

IEQ Capital increased its Aurinia Pharmaceuticals (AUPH) stake by 59% in Q1 2026, buying an estimated $120K and bringing the position to 22,088 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #1482.

IEQ Capital first reported a position in AUPH in Q1 2025 and has held it in 3 quarters since. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • IEQ Capital held 22,088 shares of Aurinia Pharmaceuticals worth $327K as of Q1 2026.
  • IEQ Capital bought 8,206 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $120K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1482 holding.
  • IEQ Capital first reported a position in Aurinia Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.